Table 2.
ApoE−/−/Gclc−/− | ApoE−/− | ApoE−/−/Gclc-Tg | ApoE−/− | |||||
---|---|---|---|---|---|---|---|---|
| ||||||||
male | female | male | female | male | female | male | female | |
| ||||||||
Cholesterol (mg/dl) | ||||||||
| ||||||||
20 weeks | 492.4±59.1 | 371.3±20.9 | 546.6±34.2 | 412.4±5.9 | 590.4±34.4 | 511.9±24.9 | 537.2±20.5 | 446.5±8.0 |
| ||||||||
30 weeks | 563.6±63.4 | 377.1±41.7 | 535.3±29.5 | 433.4±23.8 | 655.2±36.3 | 608.3±25.9 | 585.8±14.2 | 499.7±19.8 |
| ||||||||
40 weeks | 523.9±38.4 | 388.5±18.2 | 619.9±29.4 | 456.3±81.4 | 648.2±66.7 | 594.7±38.2 | 614.0±25.0 | 508.5±36.3 |
| ||||||||
50 weeks | 605.9±56.7 | 457.2±44.1 | 640.9±49.5 | 496.7±23.2 | 634.0±29.5 | 593.5±26.9 | 631.0±25.3 | 558.2±22.1 |
| ||||||||
Triglycerides (mg/dl) | ||||||||
| ||||||||
20 weeks | 582.6±94.4 | 408.5±59.8 | 551.4±93.0 | 342.2±38.8 | 626.0±52.4 | 399.1±31.6 | 551.4±34.2 | 410.4±36.3 |
| ||||||||
30 weeks | 446.9±52.3 | 299.5±22.1 | 494.3±36.9 | 243.7±30.3 | 688.2±86.3 | 506.6±55.0 | 512.7±55.1 | 469.7±10.5 |
| ||||||||
40 weeks | 474.2±47.6 | 251.0±41.9 | 503.6±47.9 | 363.9±24.3 | 523.9±38.4 | 395.5±20.1 | 497.9±45.6 | 424.8±26.0 |
| ||||||||
50 weeks | 412.4±24.0 | 305.9±35.1 | 446.4±65.9 | 327.6±29.7 | 386.4±74.6 | 206.2±65.9 | 467.7±75.2 | 357.6±41.3 |
Data are presented as the means ± SE.
Sample sizes are identical to those listed for figure 1.